LIMITLESS MD CELL Trademark

Trademark Overview


On Monday, September 10, 2018, a trademark application was filed for LIMITLESS MD CELL with the United States Patent and Trademark Office. The USPTO has given the LIMITLESS MD CELL trademark a serial number of 88110912. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, July 18, 2019. This trademark is owned by Limitless MD, LLC. The LIMITLESS MD CELL trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Umbilical stem cell products
limitless md cell

General Information


Serial Number88110912
Word MarkLIMITLESS MD CELL
Filing DateMonday, September 10, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, July 18, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesUmbilical stem cell products

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 18, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLimitless MD, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDenver, CO 80209

Trademark Events


Event DateEvent Description
Thursday, July 18, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, July 18, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, December 20, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 20, 2018NON-FINAL ACTION E-MAILED
Thursday, December 20, 2018NON-FINAL ACTION WRITTEN
Wednesday, December 19, 2018ASSIGNED TO EXAMINER
Tuesday, September 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords


cell limitless products stem umbilical